2-74461772-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006302.3(MOGS):​c.2017G>A​(p.Val673Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0108 in 1,614,216 control chromosomes in the GnomAD database, including 154 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V673A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0098 ( 17 hom., cov: 33)
Exomes 𝑓: 0.011 ( 137 hom. )

Consequence

MOGS
NM_006302.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.23

Publications

10 publications found
Variant links:
Genes affected
MOGS (HGNC:24862): (mannosyl-oligosaccharide glucosidase) This gene encodes the first enzyme in the N-linked oligosaccharide processing pathway. The enzyme cleaves the distal alpha-1,2-linked glucose residue from the Glc(3)-Man(9)-GlcNAc(2) oligosaccharide precursor. This protein is located in the lumen of the endoplasmic reticulum. Defects in this gene are a cause of type IIb congenital disorder of glycosylation (CDGIIb). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
MOGS Gene-Disease associations (from GenCC):
  • MOGS-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005691737).
BP6
Variant 2-74461772-C-T is Benign according to our data. Variant chr2-74461772-C-T is described in ClinVar as Benign. ClinVar VariationId is 218681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00983 (1498/152338) while in subpopulation NFE AF = 0.0125 (852/68036). AF 95% confidence interval is 0.0118. There are 17 homozygotes in GnomAd4. There are 771 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MOGSNM_006302.3 linkc.2017G>A p.Val673Ile missense_variant Exon 4 of 4 ENST00000448666.7 NP_006293.2 Q13724-1A0A384MDR6
MOGSNM_001146158.2 linkc.1699G>A p.Val567Ile missense_variant Exon 5 of 5 NP_001139630.1 Q13724-2Q58F09

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MOGSENST00000448666.7 linkc.2017G>A p.Val673Ile missense_variant Exon 4 of 4 1 NM_006302.3 ENSP00000410992.3 Q13724-1

Frequencies

GnomAD3 genomes
AF:
0.00985
AC:
1499
AN:
152220
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00207
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.0237
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.0327
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0125
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0112
AC:
2800
AN:
249470
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.00175
Gnomad AMR exome
AF:
0.00333
Gnomad ASJ exome
AF:
0.0249
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.0355
Gnomad NFE exome
AF:
0.0122
Gnomad OTH exome
AF:
0.0140
GnomAD4 exome
AF:
0.0109
AC:
15944
AN:
1461878
Hom.:
137
Cov.:
31
AF XY:
0.0110
AC XY:
8013
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00197
AC:
66
AN:
33478
American (AMR)
AF:
0.00324
AC:
145
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0233
AC:
610
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00616
AC:
531
AN:
86258
European-Finnish (FIN)
AF:
0.0351
AC:
1872
AN:
53408
Middle Eastern (MID)
AF:
0.0225
AC:
130
AN:
5768
European-Non Finnish (NFE)
AF:
0.0107
AC:
11929
AN:
1112010
Other (OTH)
AF:
0.0109
AC:
660
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1165
2329
3494
4658
5823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00983
AC:
1498
AN:
152338
Hom.:
17
Cov.:
33
AF XY:
0.0104
AC XY:
771
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41578
American (AMR)
AF:
0.00470
AC:
72
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
82
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4832
European-Finnish (FIN)
AF:
0.0327
AC:
347
AN:
10616
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0125
AC:
852
AN:
68036
Other (OTH)
AF:
0.0128
AC:
27
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
41
Bravo
AF:
0.00756
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00231
AC:
9
ESP6500EA
AF:
0.0114
AC:
94
ExAC
AF:
0.0107
AC:
1291
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0128
EpiControl
AF:
0.0135

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 01, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 19, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MOGS-congenital disorder of glycosylation Benign:2
Oct 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MOGS: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
13
DANN
Benign
0.86
DEOGEN2
Benign
0.0041
T;T;.;.;.
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.48
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.66
.;T;.;T;T
MetaRNN
Benign
0.0057
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L;.;.;.
PhyloP100
1.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.17
.;N;.;.;N
REVEL
Benign
0.043
Sift
Benign
0.41
.;T;.;.;T
Sift4G
Benign
0.42
.;T;.;.;T
Polyphen
0.071
B;B;.;.;.
Vest4
0.032, 0.047
MPC
0.20
ClinPred
0.0024
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.020
gMVP
0.30
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114933392; hg19: chr2-74688899; COSMIC: COSV51972342; COSMIC: COSV51972342; API